BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38016997)

  • 1. Proteomic analyses identify HK1 and ATP5A to be overexpressed in distant metastases of lung adenocarcinomas compared to matched primary tumors.
    Pasternack H; Polzer M; Gemoll T; Kümpers C; Sauer T; Lazar-Karsten P; Hinrichs S; Bohnet S; Perner S; Dressler FF; Kirfel J
    Sci Rep; 2023 Nov; 13(1):20948. PubMed ID: 38016997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers.
    Najjary S; de Koning W; Kros JM; Mustafa DAM
    Front Immunol; 2023; 14():1305644. PubMed ID: 38149244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases.
    Zhou Y; Shi X; Chen H; Mao B; Song X; Gao L; Zhang J; Yang Y; Zhang H; Wang G; Zhuang W
    Biomed Res Int; 2021; 2021():5557649. PubMed ID: 34337026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of laser-microdissected paraffin-embedded tissues: (1) Stage-related protein candidates upon non-metastatic lung adenocarcinoma.
    Kawamura T; Nomura M; Tojo H; Fujii K; Hamasaki H; Mikami S; Bando Y; Kato H; Nishimura T
    J Proteomics; 2010 Apr; 73(6):1089-99. PubMed ID: 19948256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
    Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
    Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
    Xiao G; Li L; Tanzhu G; Liu Z; Gao X; Wan X; Xiao D; Chen L; Xia X; Zhou R
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies.
    Yoshida A; Okamoto N; Tozawa-Ono A; Koizumi H; Kiguchi K; Ishizuka B; Kumai T; Suzuki N
    Hum Cell; 2013 Jun; 26(2):56-66. PubMed ID: 23504277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Proteomic Characterization of Human Lung Adenocarcinoma.
    Xu JY; Zhang C; Wang X; Zhai L; Ma Y; Mao Y; Qian K; Sun C; Liu Z; Jiang S; Wang M; Feng L; Zhao L; Liu P; Wang B; Zhao X; Xie H; Yang X; Zhao L; Chang Y; Jia J; Wang X; Zhang Y; Wang Y; Yang Y; Wu Z; Yang L; Liu B; Zhao T; Ren S; Sun A; Zhao Y; Ying W; Wang F; Wang G; Zhang Y; Cheng S; Qin J; Qian X; Wang Y; Li J; He F; Xiao T; Tan M
    Cell; 2020 Jul; 182(1):245-261.e17. PubMed ID: 32649877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypoxia-associated genes in immune infiltration and treatment options of lung adenocarcinoma.
    Liu L; Han L; Dong L; He Z; Gao K; Chen X; Guo JC; Zhao Y
    PeerJ; 2023; 11():e15621. PubMed ID: 37576511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of proteins related to prognosis of lung adenocarcinoma.
    Okayama A; Miyagi Y; Oshita F; Nishi M; Nakamura Y; Nagashima Y; Akimoto K; Ryo A; Hirano H
    J Proteome Res; 2014 Nov; 13(11):4686-94. PubMed ID: 25004236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma.
    Song H; Liu D; Wang L; Liu K; Chen C; Wang L; Ren Y; Ju B; Zhong F; Jiang X; Wang G; Chen ZS; Zou C
    Mol Cancer; 2022 Feb; 21(1):43. PubMed ID: 35144642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases.
    Naidoo K; Jones R; Dmitrovic B; Wijesuriya N; Kocher H; Hart IR; Crnogorac-Jurcevic T
    J Pathol; 2012 Apr; 226(5):756-63. PubMed ID: 22081483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.
    Sprung RW; Brock JW; Tanksley JP; Li M; Washington MK; Slebos RJ; Liebler DC
    Mol Cell Proteomics; 2009 Aug; 8(8):1988-98. PubMed ID: 19467989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
    Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
    Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.
    Tanaka I; Dayde D; Tai MC; Mori H; Solis LM; Tripathi SC; Fahrmann JF; Unver N; Parhy G; Jain R; Parra ER; Murakami Y; Aguilar-Bonavides C; Mino B; Celiktas M; Dhillon D; Casabar JP; Nakatochi M; Stingo F; Baladandayuthapani V; Wang H; Katayama H; Dennison JB; Lorenzi PL; Do KA; Fujimoto J; Behrens C; Ostrin EJ; Rodriguez-Canales J; Hase T; Fukui T; Kajino T; Kato S; Yatabe Y; Hosoda W; Kawaguchi K; Yokoi K; Chen-Yoshikawa TF; Hasegawa Y; Gazdar AF; Wistuba II; Hanash S; Taguchi A
    J Natl Cancer Inst; 2022 Feb; 114(2):290-301. PubMed ID: 34524427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9.
    Muñiz Lino MA; Palacios-Rodríguez Y; Rodríguez-Cuevas S; Bautista-Piña V; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; González-Santiago AE; Flores-Pérez A; Díaz-Chávez J; Carlos-Reyes Á; Álvarez-Sánchez E; López-Camarillo C
    J Proteomics; 2014 Dec; 111():198-211. PubMed ID: 24768906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approach.
    Lorber T; Andor N; Dietsche T; Perrina V; Juskevicius D; Pereira K; Greer SU; Krause A; Müller DC; Savic Prince S; Lardinois D; Barrett MT; Ruiz C; Bubendorf L
    J Pathol; 2019 Feb; 247(2):199-213. PubMed ID: 30350422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
    Najjary S; Kros JM; de Koning W; Vadgama D; Lila K; Wolf J; Mustafa DAM
    Acta Neuropathol Commun; 2023 Apr; 11(1):64. PubMed ID: 37061716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.